China Health Care Stock Annual Yield
| CMIM Stock | USD 0.0002 0.00 0.00% |
Fundamental analysis of China Health allows traders to better anticipate movements in China Health's stock price by examining its financial health and performance throughout various phases of its business cycle.
China |
China Health Care Company Annual Yield Analysis
China Health's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Current China Health Annual Yield | 0.12 % |
Most of China Health's fundamental indicators, such as Annual Yield, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China Health Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, China Health Care has an Annual Yield of 0.1215%. This is much higher than that of the Basic Materials sector and significantly higher than that of the Other Industrial Metals & Mining industry. The annual yield for all United States stocks is notably lower than that of the firm.
China Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Health's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of China Health could also be used in its relative valuation, which is a method of valuing China Health by comparing valuation metrics of similar companies.China Health is currently under evaluation in annual yield category among its peers.
China Fundamentals
| Return On Asset | -0.73 | |||
| Operating Margin | (3.87) % | |||
| Current Valuation | 9.03 M | |||
| Shares Outstanding | 4.18 M | |||
| Price To Sales | 0.01 X | |||
| Revenue | 545.88 K | |||
| Gross Profit | 377.77 K | |||
| EBITDA | (1.31 M) | |||
| Net Income | (2.7 M) | |||
| Cash And Equivalents | 26.63 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 3.11 M | |||
| Current Ratio | 0.08 X | |||
| Book Value Per Share | (1.35) X | |||
| Cash Flow From Operations | (1.46 M) | |||
| Earnings Per Share | (0.29) X | |||
| Number Of Employees | 14 | |||
| Beta | 0.68 | |||
| Market Capitalization | 2.53 K | |||
| Total Asset | 1.5 M | |||
| Annual Yield | 0.12 % | |||
| Net Asset | 1.5 M |
About China Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Health Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Health Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in China Pink Sheet
China Health financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Health security.